Avoid common mistakes on your manuscript.
1 Erratum to: Clin Pharmacokinet (2014) 53:837–847 DOI 10.1007/s40262-014-0161-2
Page 837; column 2, para 4: The first key point, which previously read:
Vandetanib may lead to greater exposure to octamer transcription factor-2 substrates or P-glycoprotein substrates when co-administered.
Should read:
Vandetanib may lead to greater exposure to organic cation transporter 2 substrates or P-glycoprotein substrates when co-administered.
Author information
Authors and Affiliations
Corresponding author
Additional information
The online version of the original article can be found under doi:10.1007/s40262-014-0161-2.
Rights and permissions
About this article
Cite this article
Johansson, S., Read, J., Oliver, S. et al. Erratum to: Pharmacokinetic Evaluations of the Co-Administrations of Vandetanib and Metformin, Digoxin, Midazolam, Omeprazole or Ranitidine. Clin Pharmacokinet 53, 1063 (2014). https://doi.org/10.1007/s40262-014-0193-7
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40262-014-0193-7